Checkpoint Therapeutics Announces Cosibelimab Longer-Term Results in Advanced Cutaneous Squamous Cell Carcinoma Presented at ESMO Congress 2024

Stock Information for Fortress Biotech Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Fortress Biotech Inc.

Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference
Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Checkpoint Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
Avenue Therapeutics to Participate in Upcoming Investor Conferences
Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
Checkpoint Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Updates

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.